558 related articles for article (PubMed ID: 17687154)
1. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
[TBL] [Abstract][Full Text] [Related]
2. Patients' views on financial conflicts of interest in cancer research trials.
Hampson LA; Agrawal M; Joffe S; Gross CP; Verter J; Emanuel EJ
N Engl J Med; 2006 Nov; 355(22):2330-7. PubMed ID: 17135586
[TBL] [Abstract][Full Text] [Related]
3. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
[TBL] [Abstract][Full Text] [Related]
4. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
Puttagunta PS; Caulfield TA; Griener G
Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
[TBL] [Abstract][Full Text] [Related]
5. Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants.
Friedman JY; Sugarman J; Dhillon JK; Depuy V; Pierre CK; Dinan MA; Allsbrook JS; Schulman KA; Weinfurt KP
Clin Trials; 2007; 4(3):272-8. PubMed ID: 17715256
[TBL] [Abstract][Full Text] [Related]
6. Participation in clinical trials as viewed by the patient: understanding cultural and emotional aspects which influence choice.
Catania C; De Pas T; Goldhirsch A; Radice D; Adamoli L; Medici M; Verri E; Marenghi C; de Braud F; Nolè F
Oncology; 2008; 74(3-4):177-87. PubMed ID: 18714166
[TBL] [Abstract][Full Text] [Related]
7. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
Perlis CS; Harwood M; Perlis RH
J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
[TBL] [Abstract][Full Text] [Related]
8. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research.
Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA
Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666
[TBL] [Abstract][Full Text] [Related]
9. Conflict-of-interest policies for investigators in clinical trials.
Lo B; Wolf LE; Berkeley A
N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
[TBL] [Abstract][Full Text] [Related]
10. Informed consent, capitation, and conflicts of interest in clinical trials: views from the field.
Angelos P; Murphy TF; Sampson H; Hollings DD; Kshettry V
Surgery; 2006 Nov; 140(5):740-8. PubMed ID: 17084716
[TBL] [Abstract][Full Text] [Related]
11. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials.
Markman M; Petersen J; Montgomery R
Cancer; 2006 Aug; 107(4):849-53. PubMed ID: 16832813
[TBL] [Abstract][Full Text] [Related]
12. Organizational barriers to physician participation in cancer clinical trials.
Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.
Ding EL; Powe NR; Manson JE; Sherber NS; Braunstein JB
Arch Intern Med; 2007 May; 167(9):905-12. PubMed ID: 17502531
[TBL] [Abstract][Full Text] [Related]
14. The impact of consenter characteristics and experience on patient interest in clinical research.
Rasco DW; Xie Y; Yan J; Sayne JR; Skinner CS; Dowell JE; Gerber DE
Oncologist; 2009 May; 14(5):468-75. PubMed ID: 19401521
[TBL] [Abstract][Full Text] [Related]
15. Clinical research in the private office setting--ethical issues.
Fleischman AR; Klein JE
Trans Am Clin Climatol Assoc; 2002; 113():126-35; discussion 135-6. PubMed ID: 12053705
[TBL] [Abstract][Full Text] [Related]
16. Industry-sponsored research.
Okike K; Kocher MS; Mehlman CT; Bhandari M
Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
[TBL] [Abstract][Full Text] [Related]
17. The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trials.
Zhang J; Zhang H; Yu C; Li J; Jiang Y
Contemp Clin Trials; 2011 Sep; 32(5):649-53. PubMed ID: 21570486
[TBL] [Abstract][Full Text] [Related]
18. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.
AAMC Task Force on Financial Conflicts of Interest in Clinical Research
Acad Med; 2003 Feb; 78(2):225-36. PubMed ID: 12584106
[TBL] [Abstract][Full Text] [Related]
19. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
Newcombe JP; Kerridge IH
Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
[TBL] [Abstract][Full Text] [Related]
20. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
Klanica K
J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
